FDA Orders Post-Market Studies On Metal-On-Metal Hips

FDA has ordered 21 current and former manufacturers of metal-on-metal total hip replacement systems to conduct post-market surveillance studies of their devices to assess metal toxicity risks.

More from Archive

More from Medtech Insight